<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01773343</url>
  </required_header>
  <id_info>
    <org_study_id>100169</org_study_id>
    <secondary_id>20110102</secondary_id>
    <nct_id>NCT01773343</nct_id>
  </id_info>
  <brief_title>Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals</brief_title>
  <official_title>Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals. A Randomized Controlled Trial With Blinded Response Evaluations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare efficacy and adverse effects of fractional CO2 laser of acne scars treatment with
      1 versus 3 months intervals
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Change in scar texture evaluated by blinded evalutaions. Appearance of erythema, oedema,
      pigmentation, infection after treatment
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in scar texture</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Appearance of erythema, oedema, pigmentation, infection</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Atrophic Acne Scars</condition>
  <arm_group>
    <arm_group_label>CO2 laser at 1 month interval</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CO2 laser treatment of mild to severe acne scars at 1 month interval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2 laser at 3 monrths interval</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CO2 laser treatment of mild to severe acne scars at 3 month intervals</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laser</intervention_name>
    <description>Fractionel CO2 laser: 1 versus 3 months intervals</description>
    <arm_group_label>CO2 laser at 1 month interval</arm_group_label>
    <arm_group_label>CO2 laser at 3 monrths interval</arm_group_label>
    <other_name>Fractionel CO2 laser</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have Fitzpatrick skin type I-III. (â€¢Are male or female.

          -  Are between 18 and 60 years of age.

          -  Mild to severe acne scarring.

          -  Are able to read, understand, and sign the Informed Consent.

          -  Are willing and able to comply with all follow-up requirements -

        Exclusion Criteria:

          -  Have had active localized or systemic infections within 6 months of enrollment

          -  Have compromised ability for wound healing, such as: malnutrition, oral steroid use,
             history of collagen vascular disease (e.g. lupus, scleroderma, history of keloid
             formation (raised and thickened scars), atrophic dermatitis (extreme skin irritation
             or itchiness) or immunologic abnormalities such as vitiligo (white patches of skin due
             to loss of pigment)

          -  Have been treated with lasers, chemical procedures, or other cosmetic procedures on
             the area to be treated within 6 months of enrollment

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lene Hedelund, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <state>Aarhus C</state>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2013</study_first_submitted>
  <study_first_submitted_qc>January 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2013</study_first_posted>
  <last_update_submitted>January 18, 2013</last_update_submitted>
  <last_update_submitted_qc>January 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>skin texture, efficacy, adverse effects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

